These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15547185)
1. Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. Duan W; Gao L; Druhan LJ; Zhu WG; Morrison C; Otterson GA; Villalona-Calero MA J Natl Cancer Inst; 2004 Nov; 96(22):1718-21. PubMed ID: 15547185 [TBL] [Abstract][Full Text] [Related]
2. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells. Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800 [TBL] [Abstract][Full Text] [Related]
3. Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Hattori T; Isobe T; Abe K; Kikuchi H; Kitagawa K; Oda T; Uchida C; Kitagawa M Cancer Res; 2007 Nov; 67(22):10789-95. PubMed ID: 18006823 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. Duan S; Yao Z; Hou D; Wu Z; Zhu WG; Wu M EMBO J; 2007 Jul; 26(13):3062-74. PubMed ID: 17568776 [TBL] [Abstract][Full Text] [Related]
5. Regulation of p27 by ubiquitin ligases and its pathological significance in human lung carcinomas. Dobashi Y; Tsubochi H; Minegishi K; Kitagawa M; Otani S; Ooi A Hum Pathol; 2017 Aug; 66():67-78. PubMed ID: 28601655 [TBL] [Abstract][Full Text] [Related]
6. SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma. Hu L; Liu M; Chen L; Chan TH; Wang J; Huo KK; Zheng BJ; Xie D; Guan XY Carcinogenesis; 2012 Aug; 33(8):1581-8. PubMed ID: 22570270 [TBL] [Abstract][Full Text] [Related]
7. Role of Pirh2 in mediating the regulation of p53 and c-Myc. Hakem A; Bohgaki M; Lemmers B; Tai E; Salmena L; Matysiak-Zablocki E; Jung YS; Karaskova J; Kaustov L; Duan S; Madore J; Boutros P; Sheng Y; Chesi M; Bergsagel PL; Perez-Ordonez B; Mes-Masson AM; Penn L; Squire J; Chen X; Jurisica I; Arrowsmith C; Sanchez O; Benchimol S; Hakem R PLoS Genet; 2011 Nov; 7(11):e1002360. PubMed ID: 22125490 [TBL] [Abstract][Full Text] [Related]
8. Regulation of autophagy flux by E3 ubiquitin ligase Pirh2 in lung cancer. Fedorova O; Gudovich A; Daks A; Baidyuk E; Shuvalov O; Petukhov A; Parfenyev S; Kizenko A; Barlev NA Biochem Biophys Res Commun; 2021 Jul; 563():119-125. PubMed ID: 34090148 [TBL] [Abstract][Full Text] [Related]
9. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Leng RP; Lin Y; Ma W; Wu H; Lemmers B; Chung S; Parant JM; Lozano G; Hakem R; Benchimol S Cell; 2003 Mar; 112(6):779-91. PubMed ID: 12654245 [TBL] [Abstract][Full Text] [Related]
10. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
11. [Pirh2 shRNA mediated by psiRNA-hH1 vector plasmid effectively inhibits the proliferation of lung carcinoma cells: in vitro and in vivo experiments]. Su Y; Bai M; Zhu LP; Jin Y; Zhang XJ; Zhou Q Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1199-203. PubMed ID: 17686242 [TBL] [Abstract][Full Text] [Related]
12. The Role of E3 Ligase Pirh2 in Disease. Daks A; Fedorova O; Parfenyev S; Nevzorov I; Shuvalov O; Barlev NA Cells; 2022 Apr; 11(9):. PubMed ID: 35563824 [TBL] [Abstract][Full Text] [Related]
13. Measles virus: evidence for association with lung cancer. Sion-Vardy N; Lasarov I; Delgado B; Gopas J; Benharroch D; Ariad S Exp Lung Res; 2009 Oct; 35(8):701-12. PubMed ID: 19895323 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554 [TBL] [Abstract][Full Text] [Related]
15. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53. Zheng G; Ning J; Yang YC Biochem Biophys Res Commun; 2007 Dec; 364(2):344-50. PubMed ID: 17950244 [TBL] [Abstract][Full Text] [Related]
16. TRIM65 negatively regulates p53 through ubiquitination. Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201 [TBL] [Abstract][Full Text] [Related]
17. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215 [TBL] [Abstract][Full Text] [Related]
18. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164 [TBL] [Abstract][Full Text] [Related]
19. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways. Masuya D; Huang C; Liu D; Nakashima T; Yokomise H; Ueno M; Nakashima N; Sumitomo S J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335 [TBL] [Abstract][Full Text] [Related]
20. Molecular basis of Pirh2-mediated p53 ubiquitylation. Sheng Y; Laister RC; Lemak A; Wu B; Tai E; Duan S; Lukin J; Sunnerhagen M; Srisailam S; Karra M; Benchimol S; Arrowsmith CH Nat Struct Mol Biol; 2008 Dec; 15(12):1334-42. PubMed ID: 19043414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]